Table 6.
Urinary aMT6s for placebo, DHA-rich, and EPA-rich treatment groups. Post-treatment estimated marginal means and standard error (SE) are presented with the F and p values of the main effects from the linear mixed models.
| Variable | Treatment | Post-Treatment | Main Effects | ||||
|---|---|---|---|---|---|---|---|
| n | Mean | SE | F | p | |||
| Total aMT6s (ng) | Placebo | 67 | 15,289.27 | 1,267.50 | |||
| DHA-rich | 15,335.89 | 1,267.88 | Treatment | 0.558 | 0.575 | ||
| EPA-rich | 13,585.56 | 1,346.06 | |||||
| Bedtime aMT6s (ng) | Placebo | 60 | 563.98 | 120.67 | |||
| DHA-rich | 468.62 | 123.42 | Treatment | 2.12 | 0.130 | ||
| EPA-rich | 805.34 | 117.08 | |||||